Borys Nicholas 4
4 · Celsion CORP · Filed Mar 23, 2011
Insider Transaction Report
Form 4
Celsion CORPCLSN
Borys Nicholas
VP & Chief Medical Officer
Transactions
- Conversion
Series A 8% Redeemable Convertible Preferred Stock
2011-03-23−6→ 0 totalExercise: $2.40From: 2011-01-14Exp: 2013-01-14→ Celsion Corporation Common Stock (2,500 underlying) - Conversion
Celsion Corporation Common Stock
2011-03-23$2.40/sh+2,500$6,000→ 30,687 total
Footnotes (1)
- [F1]Shares of Series A 8% Redeemable Convertible Preferred Stock with a stated value of $1,000 per share were converted to shares of Celsion Corporation Common Stock at a fixed conversion price of $2.40 per common stock.